{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T10:55:21Z","timestamp":1788432921662,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,10,22]],"date-time":"2015-10-22T00:00:00Z","timestamp":1445472000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medical-Scientific Fund of the Mayor of Vienna","award":["15028"],"award-info":[{"award-number":["15028"]}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund (AT)","doi-asserted-by":"publisher","award":["SFB-54"],"award-info":[{"award-number":["SFB-54"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s00392-015-0927-z","type":"journal-article","created":{"date-parts":[[2015,10,23]],"date-time":"2015-10-23T08:31:18Z","timestamp":1445589078000},"page":"349-355","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Morphine interaction with prasugrel: a double-blind, cross-over trial in healthy volunteers"],"prefix":"10.1007","volume":"105","author":[{"given":"Eva-Luise","family":"Hobl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Reiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Schoergenhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schwameis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulla","family":"Derhaschnig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene Marthe","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Stimpfl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Jilma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,22]]},"reference":[{"key":"927_CR1","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00392-012-0458-9","volume":"101","author":"J Wohrle","year":"2012","unstructured":"Wohrle J, Bertrand B, Sondergaard L, Turner M, Scholtz W, Ibrahim R, Bourlon F (2012) PFO closuRE and CryptogenIc StrokE (PRECISE) registry: a multi-center, international registry. Clinical research in cardiology: official journal of the German Cardiac Society. 101:787\u2013793. doi: 10.1007\/s00392-012-0458-9","journal-title":"Clinical research in cardiology: official journal of the German Cardiac Society."},{"key":"927_CR2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00392-013-0617-7","volume":"103","author":"YP Clever","year":"2014","unstructured":"Clever YP, Cremers B, von Scheidt W, Bohm M, Speck U, Scheller B (2014) Compassionate use of a paclitaxel coated balloon in patients with refractory recurrent coronary in-stent restenosis. Clin Res Cardiol Off J Ger Card Soc 103:21\u201327. doi: 10.1007\/s00392-013-0617-7","journal-title":"Clin Res Cardiol Off J Ger Card Soc"},{"key":"927_CR3","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00392-014-0720-4","volume":"103","author":"J Budzynski","year":"2014","unstructured":"Budzynski J, Kozinski M, Klopocka M, Kubica JM, Kubica J (2014) Clinical significance of Helicobacter pylori infection in patients with acute coronary syndromes: an overview of current evidence. Clin Res Cardiol Off J Ger Card Soc 103:855\u2013886. doi: 10.1007\/s00392-014-0720-4","journal-title":"Clin Res Cardiol Off J Ger Card Soc"},{"key":"927_CR4","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00392-015-0835-2","volume":"104","author":"S Waha de","year":"2015","unstructured":"de Waha S, Eitel I, Desch S, Fuernau G, Lurz P, Urban D, Schuler G, Thiele H (2015) Intravenous morphine administration and reperfusion success in ST-elevation myocardial infarction: insights from cardiac magnetic resonance imaging. Clin Res Cardiol Off J Ger Card Soc 104:727\u2013734. doi: 10.1007\/s00392-015-0835-2","journal-title":"Clin Res Cardiol Off J Ger Card Soc"},{"key":"927_CR5","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00392-011-0411-3","volume":"101","author":"T Gremmel","year":"2012","unstructured":"Gremmel T, Fruhwirth K, Kopp CW, Kaider A, Steiner S, Bakchoul T, Sachs UJ, Koppensteiner R, Panzer S (2012) Frequency of heparin\/platelet factor 4-dependent platelet antibodies in patients undergoing angioplasty and stenting for cardiovascular disease and their role for on-clopidogrel platelet reactivity. Clin Res Cardiol Off J Ger Card Soc 101:445\u2013452. doi: 10.1007\/s00392-011-0411-3","journal-title":"Clin Res Cardiol Off J Ger Card Soc"},{"key":"927_CR6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00392-013-0643-5","volume":"103","author":"R Stark","year":"2014","unstructured":"Stark R, Kirchberger I, Hunger M, Heier M, Leidl R, von Scheidt W, Meisinger C, Holle R (2014) Improving care of post-infarct patients: effects of disease management programmes and care according to international guidelines. Clin Res Cardiol Off J Ger Card Soc 103:237\u2013245. doi: 10.1007\/s00392-013-0643-5","journal-title":"Clin Res Cardiol Off J Ger Card Soc"},{"key":"927_CR7","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00392-013-0581-2","volume":"102","author":"S Liosis","year":"2013","unstructured":"Liosis S, Bauer T, Schiele R, Gohlke H, Gottwik M, Katus H, Sabin G, Zahn R, Schneider S, Rauch B, Senges J, Zeymer U (2013) Predictors of 1-year mortality in patients with contemporary guideline-adherent therapy after acute myocardial infarction: results from the OMEGA study. Clin Res Cardiol Off J Ger Card Soc 102:671\u2013677. doi: 10.1007\/s00392-013-0581-2","journal-title":"Clin Res Cardiol Off J Ger Card Soc"},{"key":"927_CR8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00392-011-0372-6","volume":"101","author":"S Desch","year":"2012","unstructured":"Desch S, Siegemund A, Scholz U, Adam N, Eitel I, de Waha S, Furnau G, Lurz P, Wetzel S, Schuler G, Thiele H (2012) Platelet inhibition and GP IIb\/IIIa receptor occupancy by intracoronary versus intravenous bolus administration of abciximab in patients with ST-elevation myocardial infarction. Clin Res Cardiol Off J Ger Card Soc 101:117\u2013124. doi: 10.1007\/s00392-011-0372-6","journal-title":"Clin Res Cardiol Off J Ger Card Soc"},{"key":"927_CR9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00392-011-0357-5","volume":"101","author":"O Zusman","year":"2012","unstructured":"Zusman O, Amit G, Gilutz H, Zahger D (2012) The significance of new onset atrial fibrillation complicating acute myocardial infarction. Clin Res Cardiol Off J Ger Card Soc 101:17\u201322. doi: 10.1007\/s00392-011-0357-5","journal-title":"Clin Res Cardiol Off J Ger Card Soc"},{"key":"927_CR10","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00392-011-0393-1","volume":"101","author":"U Zeymer","year":"2012","unstructured":"Zeymer U, Arntz HR, Mark B, Fichtlscherer S, Werner G, Scholler R, Zahn R, Diller F, Darius H, Dill T, Huber K (2012) Efficacy and safety of a high loading dose of clopidogrel administered prehospitally to improve primary percutaneous coronary intervention in acute myocardial infarction: the randomized CIPAMI trial. Clin Res Cardiol Off J Ger Card Soc 101:305\u2013312. doi: 10.1007\/s00392-011-0393-1","journal-title":"Clin Res Cardiol Off J Ger Card Soc"},{"key":"927_CR11","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1007\/s00392-014-0737-8","volume":"103","author":"CB Olivier","year":"2014","unstructured":"Olivier CB, Schnabel K, Brandt C, Weik P, Olschewski M, Zhou Q, Bode C, Diehl P, Moser M (2014) A high ratio of ADP\u2013TRAP induced platelet aggregation is associated more strongly with increased mortality after coronary stent implantation than high conventional ADP induced aggregation alone. Clin Res Cardiol Off J Ger Card Soc 103:968\u2013975. doi: 10.1007\/s00392-014-0737-8","journal-title":"Clin Res Cardiol Off J Ger Card Soc"},{"key":"927_CR12","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1161\/CIRCULATIONAHA.109.927582","volume":"122","author":"PG Steg","year":"2010","unstructured":"Steg PG, James S, Harrington RA, Ardissino D, Becker RC, Cannon CP, Emanuelsson H, Finkelstein A, Husted S, Katus H, Kilhamn J, Olofsson S, Storey RF, Weaver WD, Wallentin L (2010) Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: a platelet inhibition and patient outcomes (PLATO) trial subgroup analysis. Circulation 122:2131\u20132141. doi: 10.1161\/circulationaha.109.927582","journal-title":"Circulation"},{"key":"927_CR13","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.ahj.2005.02.010","volume":"149","author":"TJ Meine","year":"2005","unstructured":"Meine TJ, Roe MT, Chen AY, Patel MR, Washam JB, Ohman EM, Peacock WF, Pollack CV Jr, Gibler WB, Peterson ED (2005) Association of intravenous morphine use and outcomes in acute coronary syndromes: results from the CRUSADE quality improvement initiative. Am Heart J 149:1043\u20131049. doi: 10.1016\/j.ahj.2005.02.010","journal-title":"Am Heart J"},{"key":"927_CR14","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2125.1975.tb00568.x","volume":"2","author":"WS Nimmo","year":"1975","unstructured":"Nimmo WS, Heading RC, Wilson J, Tothill P, Prescott LF (1975) Inhibition of gastric emptying and drug absorption by narcotic analgesics. Br J Clin Pharmacol 2:509\u2013513","journal-title":"Br J Clin Pharmacol"},{"key":"927_CR15","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jacc.2013.10.068","volume":"63","author":"EL Hobl","year":"2014","unstructured":"Hobl EL, Stimpfl T, Ebner J, Schoergenhofer C, Derhaschnig U, Sunder-Plassmann R, Jilma-Stohlawetz P, Mannhalter C, Posch M, Jilma B (2014) Morphine decreases clopidogrel concentrations and effects: a randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol 63:630\u2013635. doi: 10.1016\/j.jacc.2013.10.068","journal-title":"J Am Coll Cardiol"},{"key":"927_CR16","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1124\/jpet.111.184895","volume":"339","author":"LM Abell","year":"2011","unstructured":"Abell LM, Liu EC (2011) Dissecting the activation of thienopyridines by cytochromes P450 using a pharmacodynamic assay in vitro. J Pharmacol Exp Ther 339:589\u2013596. doi: 10.1124\/jpet.111.184895","journal-title":"J Pharmacol Exp Ther"},{"key":"927_CR17","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1177\/0091270009343005","volume":"50","author":"NA Farid","year":"2010","unstructured":"Farid NA, Kurihara A, Wrighton SA (2010) Metabolism and disposition of the thienopyridine antiplatelet drugs ticlopidine, clopidogrel, and prasugrel in humans. J Clin Pharmacol 50:126\u2013142. doi: 10.1177\/0091270009343005","journal-title":"J Clin Pharmacol"},{"key":"927_CR18","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1021\/tx3000279","volume":"25","author":"PM Dansette","year":"2012","unstructured":"Dansette PM, Rosi J, Debernardi J, Bertho G, Mansuy D (2012) Metabolic activation of prasugrel: nature of the two competitive pathways resulting in the opening of its thiophene ring. Chem Res Toxicol 25:1058\u20131065. doi: 10.1021\/tx3000279","journal-title":"Chem Res Toxicol"},{"key":"927_CR19","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1160\/TH13-03-0263","volume":"110","author":"OO Braun","year":"2013","unstructured":"Braun OO, Angiolillo DJ, Ferreiro JL, Jakubowski JA, Winters KJ, Effron MB, Duvvuru S, Costigan TM, Sundseth S, Walker JR, Saucedo JF, Kleiman NS, Varenhorst C (2013) Enhanced active metabolite generation and platelet inhibition with prasugrel compared to clopidogrel regardless of genotype in thienopyridine metabolic pathways. Thromb Haemost 110:1223\u20131231. doi: 10.1160\/th13-03-0263","journal-title":"Thromb Haemost"},{"key":"927_CR20","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1476-5381.2009.00555.x","volume":"159","author":"JM Siller-Matula","year":"2010","unstructured":"Siller-Matula JM, Krumphuber J, Jilma B (2010) Pharmacokinetic, pharmacodynamic and clinical profile of novel antiplatelet drugs targeting vascular diseases. Br J Pharmacol 159:502\u2013517. doi: 10.1111\/j.1476-5381.2009.00555.x","journal-title":"Br J Pharmacol"},{"issue":"66","key":"927_CR21","first-page":"e9","volume":"153","author":"JT Brandt","year":"2007","unstructured":"Brandt JT, Payne CD, Wiviott SD, Weerakkody G, Farid NA, Small DS, Jakubowski JA, Naganuma H, Winters KJ (2007) A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation. Am Heart J 153(66):e9\u2013e16. doi: 10.1016\/j.ahj.2006.10.010","journal-title":"Am Heart J"},{"key":"927_CR22","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.jcin.2013.06.011","volume":"6","author":"JM Siller-Matula","year":"2013","unstructured":"Siller-Matula JM, Trenk D, Schror K, Gawaz M, Kristensen SD, Storey RF, Huber K (2013) Response variability to P2Y12 receptor inhibitors: expectations and reality. JACC Cardiovasc interv 6:1111\u20131128. doi: 10.1016\/j.jcin.2013.06.011","journal-title":"JACC Cardiovasc interv"},{"key":"927_CR23","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1160\/TH12-06-0377","volume":"109","author":"D Aradi","year":"2013","unstructured":"Aradi D, Komocsi A, Vorobcsuk A, Serebruany VL (2013) Impact of clopidogrel and potent P2Y 12 -inhibitors on mortality and stroke in patients with acute coronary syndrome or undergoing percutaneous coronary intervention: a systematic review and meta-analysis. Thromb Haemost 109:93\u2013101. doi: 10.1160\/th12-06-0377","journal-title":"Thromb Haemost"},{"key":"927_CR24","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1160\/TH12-06-0378","volume":"109","author":"JF Saucedo","year":"2013","unstructured":"Saucedo JF, Angiolillo DJ, DeRaad R, Frelinger AL 3rd, Gurbel PA, Costigan TM, Jakubowski JA, Ojeh CK, Duvvuru S, Effron MB (2013) Decrease in high on-treatment platelet reactivity (HPR) prevalence on switching from clopidogrel to prasugrel: insights from the switching anti-platelet (SWAP) study. Thromb Haemost 109:347\u2013355. doi: 10.1160\/th12-06-0378","journal-title":"Thromb Haemost"},{"key":"927_CR25","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1161\/CIRCULATIONAHA.109.912550","volume":"120","author":"PA Gurbel","year":"2009","unstructured":"Gurbel PA, Bliden KP, Butler K, Tantry US, Gesheff T, Wei C, Teng R, Antonino MJ, Patil SB, Karunakaran A, Kereiakes DJ, Parris C, Purdy D, Wilson V, Ledley GS, Storey RF (2009) Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET\/OFFSET study. Circulation 120:2577\u20132585. doi: 10.1161\/circulationaha.109.912550","journal-title":"Circulation"},{"key":"927_CR26","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1538-7836.2009.03699.x","volume":"8","author":"JM Siller-Matula","year":"2010","unstructured":"Siller-Matula JM, Christ G, Lang IM, Delle-Karth G, Huber K, Jilma B (2010) Multiple electrode aggregometry predicts stent thrombosis better than the vasodilator-stimulated phosphoprotein phosphorylation assay. J Thromb Haemost 8:351\u2013359. doi: 10.1111\/j.1538-7836.2009.03699.x","journal-title":"J Thromb Haemost"},{"key":"927_CR27","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1111\/j.1538-7836.2006.02239.x","volume":"4","author":"I Fuchs","year":"2006","unstructured":"Fuchs I, Frossard M, Spiel A, Riedmuller E, Laggner AN, Jilma B (2006) Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS. J Thromb Haemost 4:2547\u20132552. doi: 10.1111\/j.1538-7836.2006.02239.x","journal-title":"J Thromb Haemost"},{"key":"927_CR28","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1055\/s-0037-1614344","volume":"82","author":"UR Schwarz","year":"1999","unstructured":"Schwarz UR, Geiger J, Walter U, Eigenthaler M (1999) Flow cytometry analysis of intracellular VASP phosphorylation for the assessment of activating and inhibitory signal transduction pathways in human platelets\u2013definition and detection of ticlopidine\/clopidogrel effects. Thromb Haemost 82:1145\u20131152","journal-title":"Thromb Haemost"},{"key":"927_CR29","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1042\/CS20120194","volume":"123","author":"AO Spiel","year":"2012","unstructured":"Spiel AO, Derhaschnig U, Schwameis M, Bartko J, Siller-Matula JM, Jilma B (2012) Effects of prasugrel on platelet inhibition during systemic endotoxaemia: a randomized controlled trial. Clin Sci 123:591\u2013600. doi: 10.1042\/cs20120194 London, England: 1979","journal-title":"Clin Sci"},{"key":"927_CR30","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1160\/TH10-08-0530","volume":"105","author":"AO Spiel","year":"2011","unstructured":"Spiel AO, Bartko J, Schwameis M, Firbas C, Siller-Matula J, Schuetz M, Weigl M, Jilma B (2011) Increased platelet aggregation and in vivo platelet activation after granulocyte colony-stimulating factor administration. A randomised controlled trial. Thromb Haemost 105:655\u2013662. doi: 10.1160\/th10-08-0530","journal-title":"Thromb Haemost"},{"key":"927_CR31","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3109\/09537104.2010.485255","volume":"21","author":"AO Spiel","year":"2010","unstructured":"Spiel AO, Siller-Matula J, Firbas C, Leitner JM, Russmueller G, Jilma B (2010) Single dose granulocyte colony-stimulating factor markedly enhances shear-dependent platelet function in humans. Platelets 21:464\u2013469. doi: 10.3109\/09537104.2010.485255","journal-title":"Platelets"},{"key":"927_CR32","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/rcm.2813","volume":"21","author":"NA Farid","year":"2007","unstructured":"Farid NA, McIntosh M, Garofolo F, Wong E, Shwajch A, Kennedy M, Young M, Sarkar P, Kawabata K, Takahashi M, Pang H (2007) Determination of the active and inactive metabolites of prasugrel in human plasma by liquid chromatography\/tandem mass spectrometry. Rapid Commun Mass Spectrom 21:169\u2013179. doi: 10.1002\/rcm.2813","journal-title":"Rapid Commun Mass Spectrom"},{"key":"927_CR33","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/sj.clpt.6100054","volume":"81","author":"SM Huang","year":"2007","unstructured":"Huang SM, Temple R, Throckmorton DC, Lesko LJ (2007) Drug interaction studies: study design, data analysis, and implications for dosing and labeling. Clin Pharmacol Ther 81:298\u2013304. doi: 10.1038\/sj.clpt.6100054","journal-title":"Clin Pharmacol Ther"},{"key":"927_CR34","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/j.1538-7836.2007.02598.x","volume":"5","author":"A Sugidachi","year":"2007","unstructured":"Sugidachi A, Ogawa T, Kurihara A, Hagihara K, Jakubowski JA, Hashimoto M, Niitsu Y, Asai F (2007) The greater in vivo antiplatelet effects of prasugrel as compared to clopidogrel reflect more efficient generation of its active metabolite with similar antiplatelet activity to that of clopidogrel\u2019s active metabolite. J Thromb Haemost 5:1545\u20131551. doi: 10.1111\/j.1538-7836.2007.02598.x","journal-title":"J Thromb Haemost"},{"key":"927_CR35","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2165\/00003088-199528060-00001","volume":"28","author":"F Bochner","year":"1995","unstructured":"Bochner F, Lloyd JV (1995) Aspirin for myocardial infarction. Clinical pharmacokinetic considerations. Clin Pharmacokinet 28:433\u2013438","journal-title":"Clin Pharmacokinet"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-015-0927-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00392-015-0927-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-015-0927-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T17:14:14Z","timestamp":1567271654000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00392-015-0927-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,22]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["927"],"URL":"https:\/\/doi.org\/10.1007\/s00392-015-0927-z","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,22]]}}}